Use of atazanavir in hiv therapy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7072 (2006.01) A61K 31/4725 (2006.01) A61K 31/551 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2458807

A method for reducing elevated plasma LDL and/or triglyceride levels in an HIV- infected patient is disclosed. In this method, atazanavir (BMS-232632) can be used to treat HIV infection in patients exhibiting elevated plasma LDL- cholesterol and/or triglyceride levels, can be substituted for an offending HIV protease inhibitor used in such therapy, or can be used in combination with an HIV protease inhibitor metabolized by cytochrome P450 monooxygenase.

L'invention concerne un procédé de réduction de taux plasmatiques élevés de LDL et/ou de triglycérides chez un patient infecté par le VIH. Dans ce procédé, il est possible d'utiliser de l'atazanavir (BMS-232632) afin de traiter l'infection VIH chez des patients montrant des taux plasmatiques élevés de LDL et/ou de triglycérides, de le substituer à un inhibiteur de protéase de VIH délétère utilisé dans une telle thérapie, ou de l'utiliser en combinaison avec un inhibiteur de protéase de VIH métabolisé par une monooxygénase à cytochrome P450.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of atazanavir in hiv therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of atazanavir in hiv therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of atazanavir in hiv therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1821119

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.